apathy

52 ms·

181.
by apathy 10y ago
You think that bogus work doesn't siphon funds away from good quality research? What universe do you live in? With a 10% pay line, even most good research won't get funded. For bogus research to get funded, better work MUST go u
182.
by apathy 10y ago
Reminder: the terms "statistics" and "statisticians" come from the common root word "statist". I am a trained, practicing statistician (clinical and medical, not governmental) and this always gives me pause. &q
183.
by apathy 10y ago
I heard it was "worse" way "back then" but I had no idea how much worse. Without regulations and scrutiny, competitive people will push the envelope on how bad they can abuse others and for how little money. Gotta push
184.
by apathy 10y ago
Apparently the judge did not see that as a reason to prevent him from finishing his work and delivering evidence one way or the other (maybe he's awesome and his work will show this, maybe he sucks and his work will show this). "T
185.
by apathy 10y ago
This is awesome. The way that (often foreign, often on J1 or H1B or student visa) students are treated in major labs is often horrible. If this destroys Rubin's lab, so much the better. Maybe he can serve as a warning to other PIs.
186.
by apathy 10y ago
You are right, I shot from the hip. Sorry about that. I also have noprocrast set in my profile so I couldn't go back and edit it (something I thought about doing). I probably would have toned it down if I hadn't requested that H
187.
by apathy 10y ago
"Wrong" isn't the word we're looking for here, I don't think. But your above example is bullshit -- nobody puts 1000 patients at risk in a phase I (safety) trial, and if the dose isn't reasonably well calibrat
188.
by apathy 10y ago
It is a problem. You are "spending" some of your error "budget" whenever you peek prior to an endpoint. This is why if you're going to do interim analyses in clinical trials, you have to include it in the design.
189.
by apathy 10y ago
Good lord, even after all this time, ggvis' demo is still rather a disaster on mobile. Oh well, it simply isn't possible for everything to be top priority. Rstudio has done some amazing work, I'm afraid ggvis is not yet up
190.
by apathy 10y ago
This was such a beautiful comment. Elsevirus is a step down from Weekly World News. The graphical abstracts would make Jack Chick proud.
191.
by apathy 10y ago
Nice theory but there are a lot of people in Africa without a lot of money who are looking for things to eat. No safaris etc. means no justification for some of these pristine parks, least of all for enforcement. Witness the scores of eleph
192.
by apathy 10y ago
If you read Nature and science papers, plan on reading the supplementary materials (typically 20-200 pages) where we are forced to put all the real science. And the online methods (a half measure spurred by outrage at the preceding). Wouldn
193.
by apathy 10y ago
This is punishingly stupid. If you are working on a large enough project (many libraries, many developers, many organizations, daily or nightly builds because it takes 4 hours to run all the unit tests even in parallel due to dependencies)
194.
by apathy 10y ago
Sounds like an excellent argument for not using node
195.
by apathy 10y ago
Looks like they did OK...
196.
by apathy 10y ago
That's the one I was thinking of. Thank gawd.
197.
by apathy 10y ago
shit, that was true as recently as 15 years ago, from personal experience. You can't just drive down 101 from SF and buy shit at Greybar anymore?
198.
by apathy 10y ago
Possibly. I was thinking along the lines of "look at idea, see if easily, reliably, and cheaply implemented, assess market & competition, decide accordingly". Hell, even that could probably be automated. Hmm. ;-)
199.
by apathy 10y ago
I don't doubt it, but the same could be said of ML in general. Being in the right place at the right time counts for a lot.
200.
by apathy 10y ago
Re: 1: no shit. The turnaround is for rebuttals. I try to do thorough reviews (I have published plenty as well) but realistically I recognize that no one has the sort of free cycles required to catch everything in advance. What's worse
201.
by apathy 10y ago
I would literally pay to subscribe to a comments feed on posts like this. It's so obvious and so powerful, I'm sitting here kicking myself for not thinking of it first. Nearly every time I've put in a successful patent, that
202.
by apathy 10y ago
re: your last line: That is the classic industrial ML advice, isn't it? Read a bunch of papers, look at the stupid obsolete method they all compare against, implement the latter.
203.
by apathy 10y ago
1) Iowa Farm Boys can, you know, farm things 2) We're going to have to figure this out as a society unless we like the idea of Mad Max: Interstate 80. The incoming administration may or may not be ideal for the moment in time which we
204.
by apathy 10y ago
CNS (Cell, Nature, Science) == Buzzfeed science Although that's not giving BuzzFeed enough credit, they tend to check their sources & verify results/reports. Also if a piece of fake news is simply resubmitted, they don't
205.
by apathy 10y ago
The majority of content in most journals is asinine or incorrect. About the only thing that can fix this is quicker turnaround (cf STAP, NgAgo, the godawful GWAS paper in Neuron recently, etc). It's not at all clear to me that the chec
206.
by apathy 10y ago
Publishing sometimes does 1), and rarely does 2) (as a statistician you surely know that the relationship between impact factor and retraction is nonlinear and rises in strength as you get into CNS, NEJM, and the like). I review for other
207.
by apathy 10y ago
When I worked at the Cornell Theory Center in the late 90s, I didn't know about the arXiv, but I sure as hell knew about screen readers. One of the best FORTRAN programmers (numerical analysis/applied math research faculty I thin
208.
by apathy 10y ago
This is not a short or simple read. However, if you believe that the American experiment was not a mistake, and the sclerotic dynasties of Europe are a Bad Thing, it is worth the time to read through to the end. With the incoming administra
209.
by apathy 10y ago
Post your galleys to http://biorxiv.org/submit-a-manuscript when you send the MS out for review. Simple as that. Oh, and respond to RFI/RFCs from NIH asking whether interim research products should count in grant rev
210.
by apathy 10y ago
More than those, but genetic and environmental variation in their "cycles" (if you will) as well as the stochastic events involved in turning them over seems to produce extremely wide variation in their eventual readings. I work o

More ›